Effects of Pioglitazone on Asymmetric Dimethylarginine and Components of the Metabolic Syndrome in Nondiabetic Patients (EPICAMP Study): A Double-Blind, Randomized Clinical Trial
Figure 2
Number of participants with new-onset or aggravated signs and symptoms recorded during the follow-up period.